SOTERA HEALTH COMPANY
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $53.6M | $26.6M | $34.8M | $48.4M | $8.0M | $-13.3M | $12.3M | $17.0M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | $27.8M | $25.2M | $27.0M | $22.7M | $23.1M | $22.1M | $20.7M | $23.2M |
| Amortization | $5.6M | $5.6M | $5.6M | $5.6M | $11.9M | $18.7M | $19.6M | $19.9M |
| Stock-Based Compensation | $7.2M | $14.4M | $7.6M | $7.9M | $8.1M | $7.2M | $8.1M | $9.8M |
| Net Cash from Operating Activities | $88.5M | $29.4M | $103.1M | $71.2M | $57.4M | $55.5M | $55.7M | $97.5M |
| Investing Activities | ||||||||
| Capital Expenditures | $46.4M | $46.2M | $50.7M | $36.2M | $31.2M | $19.9M | $65.9M | $36.4M |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-43.3M | $-45.1M | $-50.7M | $-33.3M | $-31.2M | $-19.9M | $-65.9M | $-36.4M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $-2.4M | $-12.8M | $-8.2M | $-77.3M | $-6.9M | $-8.1M | $-6.5M | $-2.7M |
| Net Change in Cash | $40.8M | $-30.5M | $45.4M | $-33.2M | $28.2M | $27.2M | $-29.6M | $60.7M |
| Free Cash Flow | $42.0M | $-16.7M | $52.4M | $35.0M | $26.2M | $35.6M | $-10.2M | $61.1M |